Operating Lease, Liability in USD of Talis Biomedical Corp from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Talis Biomedical Corp quarterly Operating Lease, Liability history and change rate from Q2 2021 to Q2 2024.
  • Talis Biomedical Corp Operating Lease, Liability for the quarter ending 30 Jun 2024 was $18.8M, a 7.78% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Talis Biomedical Corp Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $18.8M -$1.59M -7.78% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 $19.2M +$4.53M +30.8% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $19.7M -$13.9M -41.4% 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $20.1M -$13.2M -39.7% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $20.4M -$12.7M -38.4% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $14.7M +$557K +3.94% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $33.6M +$19.6M +140% 31 Dec 2022 10-K 22 Mar 2023
Q3 2022 $33.3M +$19.2M +137% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $33.1M +$19M +135% 30 Jun 2022 10-Q 02 Aug 2022
Q1 2022 $14.2M 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $14M 31 Dec 2021 10-K 15 Mar 2022
Q3 2021 $14.1M 30 Sep 2021 10-Q 16 Nov 2021
Q2 2021 $14.1M 30 Jun 2021 10-Q 10 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.